Averin Capital Acquisition Corp. Announces Separate Trading of Shares and Warrants

The special purpose acquisition company will allow trading of its Class A ordinary shares and warrants separately starting April 10, 2026.

Apr. 8, 2026 at 8:05pm

Got story updates? Submit your updates here. ›

An extreme close-up of interlocking metal gears and machinery, representing the intricate financial infrastructure behind a SPAC's public listing.The separation of Averin Capital's shares and warrants reflects the complex financial mechanics behind a SPAC's public offering and trading.NYC Today

Averin Capital Acquisition Corp., a blank-check company focused on the intersection of technology and healthcare, announced that starting April 10, 2026, holders of the units sold in its initial public offering will be able to separately trade the company's Class A ordinary shares and warrants.

Why it matters

The ability to trade shares and warrants separately is a common milestone for SPACs as they progress towards a potential merger or acquisition target. This development signals Averin Capital's continued advancement and the market's interest in its future plans.

The details

Averin Capital said that no fractional warrants will be issued upon separation, and only whole warrants will trade. The Class A ordinary shares will trade under the symbol 'ACAA' and the warrants will trade under 'ACAAW' on the Nasdaq Global Market.

  • Averin Capital announced the separate trading will commence on April 10, 2026.
  • The company held its initial public offering at an unspecified prior date.

The players

Averin Capital Acquisition Corp.

A blank check company formed to pursue a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination, with a focus on the technology and health industries.

David Berry

The Chief Executive Officer of Averin Capital Acquisition Corp.

Got photos? Submit your photos here. ›

What’s next

Averin Capital will continue to work towards identifying a suitable merger or acquisition target in the technology and healthcare industries.

The takeaway

The separate trading of Averin Capital's shares and warrants is a typical milestone for a SPAC, signaling progress towards a potential business combination and increased market interest in the company's future plans.